I-Mab Biopharma
IMAB
$1.76
Share price
0.00%
Change (1 day)
-40.17%
Change (1 year)
Categories
P/S ratio for I-Mab Biopharma (IMAB)
P/S ratio as of May 2024 (TTM): 0.5969
According to I-Mab Biopharma's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.596896. At the end of 2020 the company had a P/S ratio of 14.2.
P/S ratio history for I-Mab Biopharma from 2020 to 2020
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2020 | 14.2 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.05 | 75.80% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 15,396.60% | 🇺🇸 USA |